Respiratory News and Research

RSS

Can the planetary health diet save your life and the planet? Study finds mixed results

Adhering to a Planetary Health Diet (PHD), which emphasizes plant-based foods, was found to reduce risks of chronic diseases and death among Chinese Singaporeans, according to a new study. However, while higher PHD scores were linked to a 7% reduction in greenhouse gas emissions, they also resulted in increased land and water usage

26 Oct 2023

$3.4 million grant awarded to identify therapeutic treatments for acute respiratory distress syndrome

A four-year, $3.4 million grant to investigate molecular mechanisms and therapeutic treatments for acute respiratory distress syndrome (ARDS) has been awarded to UTHealth Houston researchers by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

26 Oct 2023

Study helps identify children at the highest risk of severe RSV infection

A new study helps to identify children who are at the highest risk of a severe respiratory syncytial virus (RSV) infection and who would thus benefit most from new RSV prevention measures.

26 Oct 2023

Kids not the culprits: Low COVID-19 spread in U.S. child-care centers challenges closure norms

The study found that both children and care providers in U.S. child-care centers showed low rates of COVID-19 transmission, challenging the notion that these settings are high-risk environments for the virus. The results could have implications for revising guidelines on school and child-care center closures.

25 Oct 2023

New AI model aims to fix flaws in smartphone-based COVID-19 X-ray diagnosis

Researchers highlight the limitations and challenges of using AI models for diagnosing COVID-19 from chest X-rays shared via smartphones. The study introduces a new multi-task learning model to improve diagnostic accuracy, addressing issues like prediction instability and faulty focus areas in images.

25 Oct 2023

NF-κB activation during COVID-19 and its impact on patients with hypertension

Researchers review the role of NF-κB activation in the replication of SARS-CoV-2 and the impact of COVID-19 medications on NF-κB activation.

25 Oct 2023

Study finds racial disparities in receipt of low value health care

Older Black Americans are more likely to receive low value acute diagnostic tests than older White Americans, while older White Americans were more likely to receive low value screening tests and treatments, finds a study published by The BMJ today.

25 Oct 2023

Study shows benefit of convalescent plasma in Covid-19 patients requiring artificial ventilation

In a study published in The New England Journal of Medicine, clinicians and researchers from the CHU of Liège and the University of Liège show that the administration of plasma taken from convalescent donors after infection with Sars-CoV-2 to patients suffering from acute respiratory distress syndrome requiring artificial mechanical ventilation significantly reduced mortality (10%).

25 Oct 2023

Global clinical trial provides new evidence on simvastatin and vitamin C for COVID-19

The Global Coalition for Adaptive Research (GCAR) in collaboration with the University of Pittsburgh and UPMC, on behalf of the REMAP-CAP Investigator Network, announce clinical trial results examining the use of vitamin C and simvastatin to treat severely ill patients with COVID-19.

25 Oct 2023

Oxford Vaccine Group launches a pioneering study into human immunity

This study will test the responses of cells in lymph nodes before and after immunization with flu and COVID-19 vaccines and compare reactions in older and younger adults.

25 Oct 2023

Omicron's edge: boosters pressure SARS-CoV-2 to adapt and evolve

The effects of vaccine booster doses on the adaptive evolution of the virus.

25 Oct 2023

Brain clues in the battle against long COVID: study pinpoints neuroinflammation

The relationship between circulating markers of vascular dysfunction and neuroinflammation.

25 Oct 2023

BA.2.86 Omicron sub-variant shows high receptor affinity but moderate neutralization resistance

Study investigates the receptor affinity and antigenicity of the SARS-CoV-2 Omicron BA.2.86 variant, revealing that it does not show higher resistance to neutralization by human sera than other recent variants. Despite its high number of mutations and receptor affinity, the variant is slightly more sensitive to neutralization than the EG.5.1 variant, warranting continued surveillance.

24 Oct 2023

Kids with Omicron non-infectious after three days, vaccination status irrelevant

Study found that the median duration of infectivity for the Omicron variant of SARS-CoV-2 in children is three days, regardless of vaccination status. The findings suggest that current 5-day isolation policies are supported, but vaccination or booster status need not be considered in return-to-school guidelines.

24 Oct 2023

Community immunity: Steering the evolutionary course of SARS-CoV-2

Researchers in Germany have developed a comprehensive fitness model that forecasts the evolution of SARS-CoV-2 by integrating genetic, epidemiological, and immunological data. The study emphasizes the role of population immunity in shaping viral mutations and provides valuable insights into the emergence of new variants.

24 Oct 2023

COVID-19 survivors face sleep battles, with ARDS patients hardest hit, study finds

A recent study in the "Journal of Clinical Medicine" explored the long-term effects on sleep and circadian rhythms in COVID-19 survivors who experienced acute respiratory distress syndrome (ARDS). Findings revealed that a year after hospital discharge, over 91% of these patients suffered poor sleep quality, with nearly 59% experiencing insomnia, highlighting the lasting impact of COVID-19 on sleep health.

24 Oct 2023

Respiratory News and Research

Can the planetary health diet save your life and the planet? Study finds mixed results

$3.4 million grant awarded to identify therapeutic treatments for acute respiratory distress syndrome

Study helps identify children at the highest risk of severe RSV infection

Kids not the culprits: Low COVID-19 spread in U.S. child-care centers challenges closure norms

New AI model aims to fix flaws in smartphone-based COVID-19 X-ray diagnosis

NF-κB activation during COVID-19 and its impact on patients with hypertension

Study finds racial disparities in receipt of low value health care

Study shows benefit of convalescent plasma in Covid-19 patients requiring artificial ventilation

Global clinical trial provides new evidence on simvastatin and vitamin C for COVID-19

Oxford Vaccine Group launches a pioneering study into human immunity

Omicron's edge: boosters pressure SARS-CoV-2 to adapt and evolve

Brain clues in the battle against long COVID: study pinpoints neuroinflammation

BA.2.86 Omicron sub-variant shows high receptor affinity but moderate neutralization resistance

Kids with Omicron non-infectious after three days, vaccination status irrelevant

Community immunity: Steering the evolutionary course of SARS-CoV-2

COVID-19 survivors face sleep battles, with ARDS patients hardest hit, study finds

Viral rebound common in lung transplant recipients treated with nirmatrelvir/ritonavir for COVID-19

Weakened innate immunity may increase risk of severe COVID-19

Study reveals impact of hybrid immunity and booster vaccination on antibody waning

Intranasal vaccination: A potent one-time solution for comprehensive COVID-19 immunity

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News